Efficacy of Tirbanibulin 1% ointmet in the treatment of Actinic Keratosis, and surrounding solar-damaged skin (field therapy): Results from a Real-Life Study and our experience with pigmented lesions
Year: 2025
Type: article
Abstract: Background: Actinic keratosis (AKs) is a common precancerous skin lesion that tipically develops in sun exposed areas and can progress into invasive squamous cell carcinomas. Moreover, sundamaged skin can lead to cosmetic concerns, psychological distress, and an increased risk of nonmelanoma skin cancers. Tirbanibulin 1% ointment is approved for the field treatment of Olsen grade I actinic keratosis of the face and scalp. In our experience, clearance of pigmented lesions resulted in a novel desirable side effect of this agent.
Source: EJC Skin Cancer
Authors: B. Moyano, J.A. Llamas, A. Arroyo, A. Perea, G. Calvo, S. Martínez, L. Martínez
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W4409115179